Deutsche Bank’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-352
Closed -$106K 4484
2021
Q1
$106K Sell
352
-4
-1% -$1.21K ﹤0.01% 3891
2020
Q4
$133K Buy
356
+169
+90% +$63.1K ﹤0.01% 3621
2020
Q3
$58K Buy
187
+22
+13% +$6.82K ﹤0.01% 3746
2020
Q2
$62K Buy
165
+50
+43% +$18.8K ﹤0.01% 3650
2020
Q1
$26K Sell
115
-7
-6% -$1.58K ﹤0.01% 3740
2019
Q4
$63K Buy
122
+27
+28% +$13.9K ﹤0.01% 3746
2019
Q3
$40K Sell
95
-76
-44% -$32K ﹤0.01% 3914
2019
Q2
$201K Sell
171
-43
-20% -$50.5K ﹤0.01% 3741
2019
Q1
$265K Sell
214
-462
-68% -$572K ﹤0.01% 3760
2018
Q4
$639K Sell
676
-895
-57% -$846K ﹤0.01% 3142
2018
Q3
$2.26M Buy
1,571
+329
+26% +$474K ﹤0.01% 2762
2018
Q2
$2M Sell
1,242
-152
-11% -$245K ﹤0.01% 2932
2018
Q1
$2.26M Buy
1,394
+45
+3% +$73K ﹤0.01% 2763
2017
Q4
$2.26M Sell
1,349
-1,249
-48% -$2.1M ﹤0.01% 2613
2017
Q3
$3.63M Buy
2,598
+1,992
+329% +$2.79M ﹤0.01% 2098
2017
Q2
$676K Sell
606
-378
-38% -$422K ﹤0.01% 3209
2017
Q1
$533K Sell
984
-32
-3% -$17.3K ﹤0.01% 2969
2016
Q4
$618K Buy
1,016
+323
+47% +$196K ﹤0.01% 2975
2016
Q3
$495K Sell
693
-244
-26% -$174K ﹤0.01% 3114
2016
Q2
$679K Sell
937
-119
-11% -$86.2K ﹤0.01% 3064
2016
Q1
$629K Buy
1,056
+140
+15% +$83.4K ﹤0.01% 3044
2015
Q4
$523K Buy
916
+16
+2% +$9.14K ﹤0.01% 3183
2015
Q3
$503K Buy
900
+54
+6% +$30.2K ﹤0.01% 3281
2015
Q2
$672K Buy
846
+265
+46% +$210K ﹤0.01% 3153
2015
Q1
$483K Buy
581
+76
+15% +$63.2K ﹤0.01% 3236
2014
Q4
$363K Buy
505
+451
+835% +$324K ﹤0.01% 3751
2014
Q3
$37K Sell
54
-126
-70% -$86.3K ﹤0.01% 4545
2014
Q2
$151K Sell
180
-25
-12% -$21K ﹤0.01% 4108
2014
Q1
$334K Buy
+205
New +$334K ﹤0.01% 3572